Skip to content

Peritoneal Ropivacaine Infiltration on Postoperative Pain in Children Affected

Evaluate the Analgesic Effect of Intraperitoneal Infiltration of Ropivacaine in Children Undergoing Laparoscopic Surgery

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01997593
Enrollment
70
Registered
2013-11-28
Start date
2013-11-30
Completion date
2014-06-30
Last updated
2015-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colic, Testicular

Keywords

analgesia, pediatric, pain, laparoscopy, ropivacaine

Brief summary

The aim of this study was to evaluate the analgesic effect of intraperitoneal infiltration of ropivacaine in children undergoing laparoscopic surgery.

Detailed description

1. Quality assurance plan that addresses data validation and registry procedures, including any plans for site monitoring and auditing. 2. Data checks to compare data entered into the registry against predefined rules for range or consistency with other data fields in the registry. 3. Source data verification to assess the accuracy, completeness, or representativeness of registry data by comparing the data to external data sources . 4. Data dictionary that contains detailed descriptions of each variable used by the registry, including the source of the variable, coding information . 5. Standard Operating Procedures to address registry operations and analysis activities, such as patient recruitment, data collection, data management, data analysis, reporting for adverse events, and change management. 6. Sample size assessment to specify the number of participants or participant years necessary to demonstrate an effect. 7. Plan for missing data to address situations where variables are reported as missing, unavailable, non-reported, uninterpretable, or considered missing because of data inconsistency or out-of-range results 8. Statistical analysis plan describing the analytical principles and statistical techniques to be employed in order to address the primary and secondary objectives, as specified in the study protocol or plan

Interventions

DRUGintraperitoneal infiltration of ropivacaine

intraperitoneal infiltration of ropivacaine by a special equipment

Sponsors

Ping Yang
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Months to 5 Years
Healthy volunteers
No

Inclusion criteria

1. Between 6 months and 5years. 2. Laparoscopic inguinal hernia repair 3. Laparoscopic testicular descent fixation

Exclusion criteria

1. Patient who are suffering from mental disease 2. Patient who suffering from neuromuscular disease 3. Local anesthetic allergy 4. Patient who needs directly into ICU after the operation.

Design outcomes

Primary

MeasureTime frame
pain scorewithin the first 2days after the surgery

Secondary

MeasureTime frame
Analgesic doseWithin the first 2days after the surgery
Gastrointestinal function recovery scoreWithin the first 2days after the surgery
Wound scoreWithin the first 2days after the surgery
Time to dischargeParticipants will be followed for the duration of hospital stay, an expected average of 2weeks

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026